1 |
V D, P J S, Rajeev N, S AL, Chandran A, G B G, Sadanandan S. Recent Advances in Peptides-Based Stimuli-Responsive Materials for Biomedical and Therapeutic Applications: A Review. Mol Pharm 2022. [PMID: 35730605 DOI: 10.1021/acs.molpharmaceut.1c00983] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
2 |
Al Gailani M, Liu M, Wen J. Ligands for oral delivery of peptides across the blood-brain-barrier. Acta Materia Medica 2022;1. [DOI: 10.15212/amm-2021-0007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
3 |
Ding G, Zhu C, Wang Q, Cao H, Li B, Yang P, Stauber RH, Nie G, Li Z. Molecularly engineered tumor acidity-responsive plant toxin gelonin for safe and efficient cancer therapy. Bioactive Materials 2022. [DOI: 10.1016/j.bioactmat.2022.02.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
4 |
Chen S, Xu X, Li X, Yi N, Li S, Xiang X, Cheng D, Sun T. Recent advances in the intracellular delivery of macromolecule therapeutics. Biomater Sci 2022. [DOI: 10.1039/d2bm01348g] [Reference Citation Analysis]
|